Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
MDbackline, LLC
With
Allergan
Patients enrolled in this study completed a validated survey instrument (COMTOL) examining tolerability of topically applied ophthalmic medications that they are already taking in their regular course of care for glaucoma. The purpose of the study is to determine whether side effects and symptoms of the drugs already being taken cause problems with activities of daily living.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with glaucoma taking either bimatoprost or latanoprost
You may not be if
patients taking other medication or with other causes for ocular surface symptoms
Clareo Health | Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops
